ReviewOncoTargets and therapy2020

Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection.

Panagiotis Malandrakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.